The global Bioresorbable Vascular Scaffold market size is predicted to grow from US$ 324 million in 2025 to US$ 669 million in 2031; it is expected to grow at a CAGR of 12.9% from 2025 to 2031.
Bioabsorbable scaffolds, or naturally dissolving stents, that have been investigated include base materials that are either metals or polymers. Those that have been approved in markets around the world and thus have gained the most traction are based on polymers that are similar to those used in dissolvable stitches. Bioresorbable Vascular Scaffold is the scaffold that used in vascular disease.
Global Bioresorbable Vascular Scaffold key players include Abbott, Kyoto Medical, Biotronik, Elixir Medical, etc. Global top four manufacturers hold a share about 99%. Europe is the largest market, with a share about 70%, followed by Asia Pacific, with a share about 20 percent. In terms of product, Polymer BVS is the largest segment, with a share about 90%. And in terms of application, the largest application is Hospital & Clinic, followed by Medical Center.
The 鈥淏ioresorbable Vascular Scaffold Industry Forecast鈥� looks at past sales and reviews total world Bioresorbable Vascular Scaffold sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Vascular Scaffold sales for 2025 through 2031. With Bioresorbable Vascular Scaffold sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Vascular Scaffold industry.
This Insight Report provides a comprehensive analysis of the global Bioresorbable Vascular Scaffold landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Vascular Scaffold portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Bioresorbable Vascular Scaffold market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Vascular Scaffold and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Vascular Scaffold.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Vascular Scaffold market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Metal BVS
Polymer BVS
Segmentation by Application:
Hospital & Clinic
Medical Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Kyoto Medical
Biotronik
Elixir Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioresorbable Vascular Scaffold market?
What factors are driving Bioresorbable Vascular Scaffold market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioresorbable Vascular Scaffold market opportunities vary by end market size?
How does Bioresorbable Vascular Scaffold break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Bioresorbable Vascular Scaffold Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Bioresorbable Vascular Scaffold by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Bioresorbable Vascular Scaffold by Country/Region, 2020, 2024 & 2031
2.2 Bioresorbable Vascular Scaffold Segment by Type
2.2.1 Metal BVS
2.2.2 Polymer BVS
2.3 Bioresorbable Vascular Scaffold Sales by Type
2.3.1 Global Bioresorbable Vascular Scaffold Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Bioresorbable Vascular Scaffold Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Bioresorbable Vascular Scaffold Sale Price by Type (2020-2025)
2.4 Bioresorbable Vascular Scaffold Segment by Application
2.4.1 Hospital & Clinic
2.4.2 Medical Center
2.5 Bioresorbable Vascular Scaffold Sales by Application
2.5.1 Global Bioresorbable Vascular Scaffold Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Bioresorbable Vascular Scaffold Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Bioresorbable Vascular Scaffold Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Bioresorbable Vascular Scaffold Breakdown Data by Company
3.1.1 Global Bioresorbable Vascular Scaffold Annual Sales by Company (2020-2025)
3.1.2 Global Bioresorbable Vascular Scaffold Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Bioresorbable Vascular Scaffold Annual Revenue by Company (2020-2025)
3.2.1 Global Bioresorbable Vascular Scaffold Revenue by Company (2020-2025)
3.2.2 Global Bioresorbable Vascular Scaffold Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Bioresorbable Vascular Scaffold Sale Price by Company
3.4 Key Manufacturers Bioresorbable Vascular Scaffold Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioresorbable Vascular Scaffold Product Location Distribution
3.4.2 Players Bioresorbable Vascular Scaffold Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Bioresorbable Vascular Scaffold by Geographic Region
4.1 World Historic Bioresorbable Vascular Scaffold 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Bioresorbable Vascular Scaffold Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Bioresorbable Vascular Scaffold Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Bioresorbable Vascular Scaffold 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Bioresorbable Vascular Scaffold Annual Sales by Country/Region (2020-2025)
4.2.2 Global Bioresorbable Vascular Scaffold Annual Revenue by Country/Region (2020-2025)
4.3 Americas Bioresorbable Vascular Scaffold Sales Growth
4.4 APAC Bioresorbable Vascular Scaffold Sales Growth
4.5 Europe Bioresorbable Vascular Scaffold Sales Growth
4.6 Middle East & Africa Bioresorbable Vascular Scaffold Sales Growth
5 Americas
5.1 Americas Bioresorbable Vascular Scaffold Sales by Country
5.1.1 Americas Bioresorbable Vascular Scaffold Sales by Country (2020-2025)
5.1.2 Americas Bioresorbable Vascular Scaffold Revenue by Country (2020-2025)
5.2 Americas Bioresorbable Vascular Scaffold Sales by Type (2020-2025)
5.3 Americas Bioresorbable Vascular Scaffold Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioresorbable Vascular Scaffold Sales by Region
6.1.1 APAC Bioresorbable Vascular Scaffold Sales by Region (2020-2025)
6.1.2 APAC Bioresorbable Vascular Scaffold Revenue by Region (2020-2025)
6.2 APAC Bioresorbable Vascular Scaffold Sales by Type (2020-2025)
6.3 APAC Bioresorbable Vascular Scaffold Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioresorbable Vascular Scaffold by Country
7.1.1 Europe Bioresorbable Vascular Scaffold Sales by Country (2020-2025)
7.1.2 Europe Bioresorbable Vascular Scaffold Revenue by Country (2020-2025)
7.2 Europe Bioresorbable Vascular Scaffold Sales by Type (2020-2025)
7.3 Europe Bioresorbable Vascular Scaffold Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioresorbable Vascular Scaffold by Country
8.1.1 Middle East & Africa Bioresorbable Vascular Scaffold Sales by Country (2020-2025)
8.1.2 Middle East & Africa Bioresorbable Vascular Scaffold Revenue by Country (2020-2025)
8.2 Middle East & Africa Bioresorbable Vascular Scaffold Sales by Type (2020-2025)
8.3 Middle East & Africa Bioresorbable Vascular Scaffold Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioresorbable Vascular Scaffold
10.3 Manufacturing Process Analysis of Bioresorbable Vascular Scaffold
10.4 Industry Chain Structure of Bioresorbable Vascular Scaffold
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioresorbable Vascular Scaffold Distributors
11.3 Bioresorbable Vascular Scaffold Customer
12 World Forecast Review for Bioresorbable Vascular Scaffold by Geographic Region
12.1 Global Bioresorbable Vascular Scaffold 麻豆原创 Size Forecast by Region
12.1.1 Global Bioresorbable Vascular Scaffold Forecast by Region (2026-2031)
12.1.2 Global Bioresorbable Vascular Scaffold Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Bioresorbable Vascular Scaffold Forecast by Type (2026-2031)
12.7 Global Bioresorbable Vascular Scaffold Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Bioresorbable Vascular Scaffold Product Portfolios and Specifications
13.1.3 Abbott Bioresorbable Vascular Scaffold Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Kyoto Medical
13.2.1 Kyoto Medical Company Information
13.2.2 Kyoto Medical Bioresorbable Vascular Scaffold Product Portfolios and Specifications
13.2.3 Kyoto Medical Bioresorbable Vascular Scaffold Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Kyoto Medical Main Business Overview
13.2.5 Kyoto Medical Latest Developments
13.3 Biotronik
13.3.1 Biotronik Company Information
13.3.2 Biotronik Bioresorbable Vascular Scaffold Product Portfolios and Specifications
13.3.3 Biotronik Bioresorbable Vascular Scaffold Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biotronik Main Business Overview
13.3.5 Biotronik Latest Developments
13.4 Elixir Medical
13.4.1 Elixir Medical Company Information
13.4.2 Elixir Medical Bioresorbable Vascular Scaffold Product Portfolios and Specifications
13.4.3 Elixir Medical Bioresorbable Vascular Scaffold Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Elixir Medical Main Business Overview
13.4.5 Elixir Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
